Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.17 USD -5.95%
Market Cap: 546.4m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one PHAT stock under the Base Case scenario is 12.09 USD. Compared to the current market price of 9.17 USD, Phathom Pharmaceuticals Inc is Undervalued by 24%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHAT Relative Value
Base Case
12.09 USD
Undervaluation 24%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
17
vs Industry
2
Median 3Y
0
Median 5Y
0
Industry
2.6
Forward
11.8
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-4.9
Industry
23
Forward
-1.5
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-6.2
Industry
17.8
vs History
vs Industry
24
Median 3Y
-5.8
Median 5Y
-9.5
Industry
25.4
vs History
vs Industry
39
Median 3Y
-4.7
Median 5Y
8.1
Industry
2.2
vs History
17
vs Industry
2
Median 3Y
0
Median 5Y
0
Industry
2.8
Forward
15.3
vs History
17
vs Industry
1
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-5.6
Industry
13.7
Forward
-2.5
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-5.5
Industry
17.2
Forward
-2.5
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-6
Industry
16.5
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.9
Industry
19.3
vs History
63
vs Industry
4
Median 3Y
30.3
Median 5Y
29.4
Industry
2

Multiples Across Competitors

PHAT Competitors Multiples
Phathom Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
547m USD 20.8 -1.6 -2.5 -2.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Average P/E: 33.4
Negative Multiple: -1.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top